CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 80 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $366,000 | -7.1% | 200,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $394,000 | +282.5% | 200,000 | +1251.4% | 0.01% | +600.0% |
Q1 2019 | $103,000 | +19.8% | 14,800 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $86,000 | -91.9% | 14,800 | -89.5% | 0.00% | -90.0% |
Q3 2018 | $1,062,000 | – | 140,715 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
Aries Wealth Management | 27,900 | $160,000 | 0.10% |
Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |